Opioid Safety Seminar & Panel Discussion

August 11, 2022:
CDC streamlines COVID-19 guidance to help the public better protect themselves and understand their risk

The CDC has streamlined its COVID-19 guidance to help people better understand their risk, how to protect themselves and others, what actions to take if exposed to COVID-19, and what actions to take if they are sick or test positive for the virus.

CDC Newsroom | COVID-19 Guidance Update

Questions or comments for the Safe Opioid Task Force

The MOA established the Safe Opioid Task Force in 2015. The Task Force works to advocate on behalf of physicians and the patients they serve on the issues of preventing addiction, treating addiction, and providing information on safe prescribing guidelines.

Questions or Comments
If you have questions, comments or concerns regarding the information being shared, please use this form. Your submission will be forwarded to members of the Task Force. The time is takes to reply may depend on the issue.

Safe Opioid Task Force Question/Comment form

Proposed CDC Clinical Practice Guideline for Prescribing Opioids - Public Comments are being accepted

Proposed CDC Clinical Practice Guideline for Prescribing Opioids–United States, 2022 that can be found in the following URL within the Federal Register - Federal Register :: Proposed 2022 CDC Clinical Practice Guideline for Prescribing Opioids. This update provides key revisions from the 2016 version, particularly for those who have chronic disease that incites severe intractable and largely incurable pain.

Prescribing Opioids—United States, 2022 (the clinical practice guideline). The clinical practice guideline updates and expands the CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016, and provides evidence-based recommendations for clinicians who provide pain care, including those prescribing opioids, for outpatients age 18 years and older with acute pain (duration less than 1 month), subacute pain (duration of 1-3 months), or chronic pain (duration of 3 months or more), not including sickle cell disease-related pain management, cancer pain treatment, palliative care, and end-of-life care. The clinical practice guideline includes recommendations for primary care clinicians (including physicians, nurse practitioners, and physician assistants) as well as for outpatient clinicians in other specialties (including those managing dental and post-surgical pain in outpatient settings and emergency clinicians providing pain management for patients being discharged from emergency departments). This voluntary clinical practice guideline provides recommendations and does not require mandatory compliance; and the clinical practice guideline is intended to be flexible so as to support, not supplant, clinical judgment and individualized, patient-centered decision-making.

CDC Clinical Practice Guideline for Prescribing Opioids

2016 vs. 2022 CDC Opioid Guideline comparison (PDF) from the U.S. Pain Foundation

5 Strategic Pillars to Combat opioid abuse

The Michigan Osteopathic Association (MOA) has developed a strategy for combating the opioid crisis facing Michigan. The MOA's "5 Strategic Pillars" were developed based on recommendations from the MOA Presidential Task Force on Safe Opioid Use, the Michigan Governor's Task Force and The Office of the White House.

On this page, you will find news and info about efforts from the MOA and around Michigan to lessen the burden of the opioid epidemic, a full cadre of resources and useful links for both providers and patients and a section on the MOA Presidential Task Force on Safe Opioid Use.

Goal - reduce opioid-related deaths and morbidity, while we treat patients with pain and/or addiction with compassion and expertise.
Click here for the 5 Strategic Pillars